 LEXINGTON, Mass., July 8, 2021 PRNewswire -- LogicBio Therapeutics, Inc. Nasdaq:LOGC, a clinical-stage genetic medicine company pioneering gene editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood, today announced that Frederic Chereau, chief executive officer of LogicBio, will participate in a virtual panel discussion entitled Delivery and Durability of Genetic Medicines at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, 2021 at 10:00 a.m. 